Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway-Reference-Cited by-同舟云学术

Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway

Published:2017-10 Issue: Volume:190 Page:169-176
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Wu Jin-Lu,Zou Jia-Yun,Hu En-De,Chen Da-Zhi,Chen Lu,Lu Feng-Bin,Xu Lan-Man,Zheng Ming-Hua,Li Hui,Huang Yu,Jin Xiao-Ya,Gong Yue-Wen,Lin Zhuo,Wang Xiao-Dong,Zhao Ming-Fang,Chen Yong-Ping

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Autoimmune hepatitis: a review of current diagnosis and treatment;Makol;Hepat. Res. Treat.,2011

2. Aetiopathogenesis of autoimmune hepatitis;Longhi;J. Autoimmun.,2010

3. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis;Czaja;Clin. Gastroenterol. Hepatol.,2008

4. Role of international criteria in the diagnosis of autoimmune hepatitis;Abdollahi;World J. Gastroenterol.,2013

5. Autoimmune hepatitis;Heneghan;Lancet,2013

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies;Biomedicines;2024-06-24

2. Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies;Best Practice & Research Clinical Rheumatology;2024-05

3. Dietary fiber (oligosaccharide and non-starch polysaccharide) in preventing and treating functional gastrointestinal disorders — Challenges and controversies: A review;International Journal of Biological Macromolecules;2024-02

4. Fecal microbiota transplantation regulates TFH/TFR cell imbalance via TLR/MyD88 pathway in experimental autoimmune hepatitis;Heliyon;2023-10

5. Short chain fatty acids, a possible treatment option for autoimmune diseases;Biomedicine & Pharmacotherapy;2023-07